kezar life sciences stock news

Kezar Life Sciences Inc Registered Shs Stock KZR. Kezar to Host Virtual Investor and Analyst Day on November 15 2021.

Kzr Institutional Ownership Kezar Life Sciences Inc Nasdaq Stock

Kezar Life Sciences News.

. KZR a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and o. Why Kezar Life Sciences Stock. Possible turnaround for Kezar Life Sciences Inc.

On average analysts give Kezar Life Sciences Inc a Strong Buy rating. Kezar Life Sciences Inc. Their forecasts range from 1400 to 2200.

5 months ago - Business Wire. Why Kezar Life Sciences Stock Is Soaring Today Nov. Provided by Business Wire Mar 17 2022 101 PM PDT.

Find the latest Kezar Life Sciences Inc. That average ranking earns Kezar Life Sciences Inc an Analyst Rating of 72 which is better than 72 of stocks based on data compiled by InvestorsObserver. Recent News View All News.

Nov 11 2021 700am EST. The average price target is 19 which means analysts expect the stock to rise by 21720 over the next twelve months. KZR stock price quote stock graph news analysis.

The stock is currently up 2023 year-to-date up 1833 over the past 12 months and down 111 over the past five years. KZR stock quote history news and other vital information to help you with your stock trading and investing. -- Business Wire Kezar Life Sciences Inc.

44944 shares of the stock were exchanged compared to its average. Berger bought 60000 shares of Kezar Life Sciences stock in a transaction dated Friday March 18th. On average they anticipate Kezar Life Sciences stock price to reach 1667 in the next year.

Kezar Life Sciences Inc KZR shares closed today at 07 below its 52 week high of 1634 giving the company a market cap of 775M. For autoimmune inflammatory disorders SA News Fri Oct. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.

2 days agoIn other Kezar Life Sciences news Director Franklin M. Get the latest Kezar Life Sciences Inc. 16 2021 at 1138 am.

A high-level overview of Kezar Life Sciences Inc. Is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to. Kezar Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update.

Berger purchased 60000 shares of the businesss stock in a transaction on Friday March 18th. Kezar Life Sciences NASDAQKZR - Get Rating posted its quarterly earnings data on ThursdayThe company reported 026 earnings per share for the quarter topping analysts consensus estimates of 028 by 002 MarketWatch Earnings reports. Real time Kezar Life Sciences Inc.

Get Kezar Life Sciences Inc KZRNASDAQ real-time stock quotes news price and financial information from CNBC. 2 days agoIn other news Director Franklin M. KZR traded up 022 on Friday reaching 574.

ET on Motley Fool Kezar Life Sciences KZR Gets a Buy Rating from HC. 23 2020 Encouraging lupus data lifts Kezar Life Sciences up 9 after hours. The stock was bought at an average cost of 1674 per share.

Kezar Life Sciences to Participate. SOUTH SAN FRANCISCO Calif. KZR a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders today reported financial results for the first quarter ended March 31 2022 and provided a business update.

3 brokers have issued 12-month price targets for Kezar Life Sciences shares. Kezar Life Sciences KZR-616 an Orphan Drug in US. Kezar Announces Inducement Grants Under NASDAQ Listing Rule 5635c4 May 5 2022 430pm EDT.

A vertical stack of three evenly spaced horizontal lines. Kezar Life Sciences to Present at the Jefferies London Healthcare Conference. This is the News-site for the company Kezar Life Sciences on Markets Insider.

NASDAQKZR insiders still down US17k after a US13m shopping spree. SOUTH SAN FRANCISCO Calif-- BUSINESS WIRE--Kezar Life Sciences Inc. KZR stock news and headlines to help you in your trading and investing decisions.

Kezar Life Sciences climbs after over 1 million insider purchase.

Could The Kezar Life Sciences Inc Nasdaq Kzr Ownership Structure Tell Us Something Useful